Search

Search Constraints

You searched for: Author/Creator Alama, Angela

Search Results

11. Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I–III Non-Small Cell Lung Cancer. (17th November 2015)

13. Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives. (3rd October 2022)

14. Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer. (4th May 2017)

15. Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. (July 2014)

16. Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy. (July 2014)

17. Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. (3rd June 2019)

18. New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer. (2nd January 2017)

19. Oral vinorelbine in the treatment of non-small-cell lung cancer. (August 2014)

20. Oral vinorelbine in the treatment of non-small-cell lung cancer. (August 2014)